Stem cell-based therapy for pulmonary fibrosis
Abstract Pulmonary fibrosis (PF) is a chronic and relentlessly progressive interstitial lung disease in which the accumulation of fibroblasts and extracellular matrix (ECM) induces the destruction of normal alveolar structures, ultimately leading to respiratory failure. Patients with advanced PF are...
Main Authors: | Wenzhao Cheng, Yiming Zeng, Dachun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-022-03181-8 |
Similar Items
-
Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
by: Sevindzh Kletukhina, et al.
Published: (2022-09-01) -
Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics
by: Yu Fujita
Published: (2022-08-01) -
Mesenchymal Stem Cells in Radiation-Induced Pulmonary Fibrosis: Future Prospects
by: Yusha Chen, et al.
Published: (2022-12-01) -
The Emerging Role of Extracellular Vesicles from Mesenchymal Stem Cells and Macrophages in Pulmonary Fibrosis: Insights into miRNA Delivery
by: Shuang Li, et al.
Published: (2022-10-01) -
Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
by: Simona-Rebeca Nazarie (Ignat), et al.
Published: (2021-12-01)